Page 1 of Clinical Trials for Rebif, 149 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers
Last Updated: June 3, 2009
Condition(s): Multiple Sclerosis
2
Completed
Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis
Last Updated: January 26, 2010
Condition(s): Multiple Sclerosis
3
Completed
An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple Sclerosis
Last Updated: June 10, 2010
Condition(s): Multiple Sclerosis
4
Recruiting
Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting.
Last Updated: August 8, 2011
Condition(s): Multiple Sclerosis
5
Recruiting
Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farmaceutico Bergamo Compared to Interferon Beta-1a (Rebif - Merck Serono) in Healthy Subjects
Last Updated: February 10, 2011
Condition(s): Healthy
6
Recruiting
Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment
Last Updated: January 12, 2012
Condition(s): Relapsing-Remitting Multiple Sclerosis
7
Recruiting
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis
Last Updated: May 21, 2012
Condition(s): Multiple Sclerosis, Relapsing-Remitting
8
Recruiting
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis
Last Updated: May 21, 2012
Condition(s): Multiple Sclerosis, Relapsing-Remitting
9
Active, not recruiting
Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®
Last Updated: September 30, 2011
Condition(s): Multiple Sclerosis, Relapsing-Remitting
10
Completed
Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS)
Last Updated: November 3, 2011
Condition(s): Multiple Sclerosis
11
Completed
Rebif New Formulation (RNF) Quality of Life (QOL) Study
Last Updated: August 17, 2010
Condition(s): Relapsing Multiple Sclerosis
12
Active, not recruiting
Combination Therapy Using Cellcept and Rebif in RRMS
Last Updated: October 17, 2011
Condition(s): Multiple Sclerosis
13
Completed
Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS
Last Updated: December 22, 2011
Condition(s): Relapsing-remitting Multiple Sclerosis
14
Completed
Immunogenicity and Safety Study of Serum-Free Avonex
Last Updated: June 5, 2009
Condition(s): Multiple Sclerosis
15
Recruiting
Treatment Adherence When Using RebiSmart™ in Relapsing Multiple Sclerosis Subjects
Last Updated: April 27, 2012
Condition(s): Multiple Sclerosis; MS
16
Completed
A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease
Last Updated: March 7, 2012
Condition(s): Alzheimer's Disease
17
Completed
A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone
Last Updated: May 11, 2011
Condition(s): Multiple Sclerosis, Relapsing-Remitting
18
Completed
Study To Evaluate The Immunogenicity And Safety Of r-hIFN Beta-1a (Rebif®) Using Clone 484-39 In Multiple Sclerosis
Last Updated: April 1, 2011
Condition(s): Relapsing Remitting Multiple Sclerosis
19
Completed
Transition to Rebif New Formulation
Last Updated: September 27, 2011
Condition(s): Relapsing Multiple Sclerosis
20
Completed
Safety, Tolerability and Adherence With Rebif® New Formulation in Real Life Settings (STAR)
Last Updated: October 6, 2011
Condition(s): Multiple Sclerosis, Relapsing Remitting

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Rebif

Page 1 of Clinical Trials for Rebif, 149 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About